Unknown

Dataset Information

0

Focal hemosiderin deposits and ?-amyloid load in the ADNI cohort.


ABSTRACT: Prevalence and risk factors for focal hemosiderin deposits are important considerations when planning amyloid-modifying trials for treatment and prevention of Alzheimer's disease (AD).Subjects were cognitively normal (n = 171), early-mild cognitive impairment (MCI) (n = 240), late-MCI (n = 111), and AD (n = 40) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Microhemorrhages and superficial siderosis were assessed at baseline and on all available MRIs at 3, 6, and 12 months. ?-amyloid load was assessed with (18)F-florbetapir positron emission tomography.Prevalence of superficial siderosis was 1% and prevalence of microhemorrhages was 25% increasing with age (P < .001) and ?-amyloid load (P < .001). Topographic densities of microhemorrhages were highest in the occipital lobes and lowest in the deep/infratentorial regions. A greater number of microhemorrhages at baseline was associated with a greater annualized rate of additional microhemorrhages by last follow-up (rank correlation = 0.49; P < .001).Focal hemosiderin deposits are relatively common in the ADNI cohort and are associated with ?-amyloid load.

SUBMITTER: Kantarci K 

PROVIDER: S-EPMC3770782 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.

Kantarci Kejal K   Gunter Jeffrey L JL   Tosakulwong Nirubol N   Weigand Stephen D SD   Senjem Matthew S MS   Petersen Ronald C RC   Aisen Paul S PS   Jagust William J WJ   Weiner Michael W MW   Jack Clifford R CR  

Alzheimer's & dementia : the journal of the Alzheimer's Association 20130130 5 Suppl


<h4>Background</h4>Prevalence and risk factors for focal hemosiderin deposits are important considerations when planning amyloid-modifying trials for treatment and prevention of Alzheimer's disease (AD).<h4>Methods</h4>Subjects were cognitively normal (n = 171), early-mild cognitive impairment (MCI) (n = 240), late-MCI (n = 111), and AD (n = 40) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Microhemorrhages and superficial siderosis were assessed at baseline and on all available M  ...[more]

Similar Datasets

| S-EPMC2964411 | biostudies-literature
| S-EPMC3256261 | biostudies-literature
| S-EPMC4927890 | biostudies-literature
| S-EPMC2975378 | biostudies-literature
| S-EPMC4833870 | biostudies-literature
| S-EPMC2840723 | biostudies-literature
| S-EPMC4573220 | biostudies-literature
| S-EPMC2953836 | biostudies-literature
| S-EPMC7233422 | biostudies-literature
| S-EPMC6448463 | biostudies-literature